Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid Cancer

NCT07703163 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
SGLT 2 Inhibitors

Interventions

DRUG: Canagliflozin

Sponsor

West China Hospital